![]() |
市場調查報告書
商品編碼
1348456
靜脈內空氣濾淨器全球市場:規模,佔有率,趨勢分析(2024年~2030年):MedCoreIntravenous Filter Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2023年,全球靜脈過濾器市場規模為1.593億美元,較2022年的1.517億美元成長5.0%。展望未來,預計複合年增長率 (CAGR) 為 4.2%,最終達到 2.127 億美元。目前,全球靜脈過濾器市場由 Pall 公司、GVS、ITW Filtertek 等公司主導。
醫療保健產業越來越認識到靜脈治療中病人安全的重要性。在全球範圍內,監管機構和醫療保健組織越來越注重維持病患照護的最高標準。為了滿足這些嚴格的標準,醫療保健提供者必須遵守美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等知名機構制定的指南和法規。這些監管機構在促進靜脈過濾器作為標準醫療方案的組成部分的廣泛使用方面發揮著至關重要的作用。透過確保遵守這些準則,醫療保健提供者可以自信地確保患者健康並維持最高品質的照護。
頗爾公司是全球靜脈過濾器市場的領導者,並享有重要的市場佔有率。該公司的大部分輸液過濾器作為 OEM 設備透過輸液器和輸液幫浦的主要供應商銷售。頗爾公司的產品系列包括孔徑0.2μm和1.2μm的過濾器,著名的Supor(R)品牌也被靜脈輸液器市場的領先競爭對手所採用。
GVS 在全球輸液過濾器市場中排名第二。該公司主要作為過濾器的 OEM 運營,然後由其他主要 IV 設備製造商銷售。GVS 提供多種液體滴濾器選擇,以滿足各種過濾要求,其中包括 Speedflow 品牌,其過濾器孔徑為 0.2、1.2 和 5.0 微米。
ITW Filtertek 專門為其他 OEM 製造作為整合部件的線上過濾器。該公司的產品線包括設計用於靜脈給藥、全身腸外營養 (TPN)、輸血和水注射的過濾器。該公司提供與各種標準孔徑過濾器和管道的整合選項。
本報告提供全球靜脈內過濾器市場相關調查,提供市場概要,以及各市場區隔,各地區趨勢,競爭情形等資訊。
In 2023, the worldwide intravenous filter market exhibited a total worth of $159.3 million, marking a 5.0% upturn from the $151.7 million recorded in 2022. Projections for the upcoming period indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 4.2%, ultimately reaching $212.7 million. Presently, the global intravenous filter market is under the dominance of Pall Corporation, GVS, and ITW Filtertek.
Our comprehensive medical market research encompassed an extensive analysis of more than 10 intravenous filter companies across seven continents. Employing a rigorous methodology, we delved into market sizes, unit sales, company market shares, and generated precise forecasts.
The healthcare industry is increasingly acknowledging the paramount significance of patient safety throughout intravenous (IV) therapy. Globally, regulatory authorities and healthcare institutions are placing growing emphasis on maintaining the highest standards of patient care. To meet these stringent standards, healthcare providers are required to adhere to guidelines and regulations established by renowned organizations such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These regulatory bodies play a pivotal role in driving the widespread adoption of IV filters as an essential component of standard healthcare protocols. By steadfastly adhering to these guidelines, healthcare providers can confidently ensure the well-being of their patients and uphold the highest quality of care.
Pall Corporation stands as the frontrunner in the global IV filter market, boasting a substantial market share. The majority of its IV filters are distributed as original equipment manufacturer (OEM) devices through prominent suppliers of IV sets and IV pumps. Pall Corporation's product range encompasses filters with pore sizes of 0.2 and 1.2 micrometers, including the renowned Supor® brand, which is also employed by major competitors in the IV set market.
Securing the second position in the global IV filtration market is GVS. This company primarily operates as an OEM for filters, which are subsequently marketed and sold by other leading suppliers of IV devices. GVS offers a diverse selection of liquid IV filters, including the Speedflow brand, featuring filters with pore sizes of 0.2, 1.2, and 5.0 micrometers to cater to various filtration requirements.
ITW Filtertek specializes in producing in-line filters as integral components for other OEMs. Its product line encompasses filters designed for drug administration through infusion, total parenteral nutrition (TPN), blood transfusion, and aqueous solution infusions. The company offers a range of filters with different standard pore sizes and integration options with tubing.